Type of Arrangement and Non-arrangement Transactions [Axis]
Exclusive License Agreement [Member]
Debt Instrument [Axis]
Robert Salna Promissory Note [Member]
Equity Components [Axis]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings (Deficit) [Member]
Class of Stock [Axis]
Series A Convertible Preferred Stock [Member]
Related Party [Axis]
Investor [Member]
Antidilutive Securities [Axis]
Outstanding Options [Member]
Outstanding Warrants [Member]
Plan Name [Axis]
2015 Long-term Incentive Plan [Member]
Exercise Price Range [Axis]
Exercise Price 0.55 [Member]
Exercise Price 2.00-3.85 [Member]
Exercise Price 5.10-7.20 [Member]
Exercise Price 0.55-7.20 [Member]
Award Date [Axis]
2019 [Member]
2020 [Member]
Ownership [Axis]
Beneficial Ownership [Member]
Series A Preferred Stock [Member]
Additional Paid-In-Capital [Member]
Accumulated Deficit [Member]
Convertible Preferred Stock [Member]
Issued and Outstanding Convertible Preferred Stock [Member]
Document And Entity Information
Entity Registrant Name
Entity Central Index Key
Document Type
Document Period End Date
Amendment Flag
Current Fiscal Year End Date
Entity Filer Category
Entity Small Business Flag
Entity Emerging Growth Company
Entity Ex Transition Period
Entity Common Stock, Shares Outstanding
Trading Symbol
Document Fiscal Period Focus
Document Fiscal Year Focus
Statement of Financial Position [Abstract]
ASSETS:
Current Assets
Cash and cash equivalents
Accounts receivables, net
Inventory
Prepaid expenses
Total current assets
Other Assets
Property and equipment, net
Investment in joint venture
Total other assets
Total assets
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT):
Current Liabilities
Accounts payable
Accrued expenses
Accrued expenses (related party)
Notes payable net of discount of $0 and $91,428
Total current liabilities
Long-term Liabilities, net of current portion
Accrued expenses-long-term (related party)
Total long-term liabilities, net of current portion
Total liabilities
Commitments and contingencies
STOCKHOLDERS' EQUITY (DEFICIT):
Convertible preferred stock, $.001 par value; 5,000,000 shares authorized, 28,000 and no shares issued and outstanding, respectively
Common stock, $.001 par value, 100,000,000 shares authorized; 17,015,766 and 12,923,373 shares issued and outstanding, respectively.
Additional paid-in capital
Accumulated deficit
Total stockholder' equity (deficit)
Total liabilities and stockholders' equity (deficit)
Current notes payable related party, discount
Preferred stock, par value
Preferred stock, shares authorized
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Income Statement [Abstract]
Net sales
Cost of sales
Gross profit
Operating expenses:
Sales and marketing
Administrative and general
Research and development
Depreciation and amortization
Total operating expenses
Loss from operations
Other expense:
Interest income
Interest expense
Gain on disposition of assets
Loss on equity method investment in joint venture
Total other expense
Loss before income taxes
Provision for income taxes
Net loss
Basic and diluted income (loss) per common share
Weighted average common shares outstanding, basic and diluted
Statement of Cash Flows [Abstract]
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Stock based compensation
Accretion of notes payable discount
Gain on disposition of assets
Loss of equity method investment
Changes in assets and liabilities:
(Increase) in accounts and other receivables
Decrease in deferred income
(Increase) decrease in prepaid and other assets
Increase in inventory
Increase (decrease) in accounts payable and accrued expenses
Net cash used in operating activities
Cash flows from investing activities:
Purchase of property and equipment
Investment in joint venture
Net cash used by investing activities
Cash flows from financing activities:
Proceeds from sale of common stock
Proceeds from sale of preferred stock
Payment of offering costs
Net cash provided by financing activities
Net increase (decrease) in cash
Cash and cash equivalents beginning of period
Cash and cash equivalents end of period
Supplemental disclosure of cash flow information:
Interest paid
Income taxes paid
Accounting Policies [Abstract]
Basis of Presentation
Significant Accounting Policies
Equity [Abstract]
Equity
Debt Disclosure [Abstract]
Notes Payable
Share-based Payment Arrangement [Abstract]
Stock-Based Compensation
Related Party Transactions [Abstract]
Related Party Transactions
Insurance [Abstract]
Lease Obligations
Subsequent Events [Abstract]
Subsequent Events
Earnings (Loss) Per Share
Use of Estimates
Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity
Summary of Option Activity
Summary of Warrant Activity
Summary of Stock Option and Warrant Outstanding
Schedule of Unrecognized Stock-based Compensation
Schedule of Lease Rent Obligations
Statement [Table]
Statement [Line Items]
Antidilutive securities potentially dilutive shares
Number of common stock issued
Number of common stock issued, value
Purchase price paid
Convertible note payable related parties
Equity ownership percentage
Sales of equity common stock
Sales of common stock price per shares
Issuance of common stock gross proceeds
Proceeds from issuance of initial public offering
Offering costs
Conversion of common stock converted
Conversion of stock, amount converted
Stock conversion price per share
Number of common stock issued for services
Number of common stock issued for services, value
Beginning balance
Beginning balance, shares
Public offering, net of offering costs of $592,764
Public offering, net of offering costs of $592,764, shares
Issuance of Preferred Stock
Issuance of Preferred Stock, shares
Stock-based compensation expense
Conversion of Preferred Stock to Common
Conversion of Preferred Stock to Common, shares
Issuance of Common Stock for Services
Issuance of Common Stock for Services, shares
Ending balance
Ending balance, shares
Debt principal amount
Unamortized debt discount
Interest expense
Interest expense for accretion
Aggregate number of common shares reserved
Unissued common stock options authorized shares
Number of options granted
Weighted average fair value of options granted
Stock-based compensation expense related to granted
Warrants issued
Unrecognized stock-based compensation
Options Outstanding, Beginning
Options Outstanding, Option granted
Options Outstanding, Expired
Options Outstanding, Forfeited options
Options Outstanding, Exercised
Options Outstanding, Ending
Weighted Average Exercise Price Outstanding, Beginning
Weighted Average Exercise Price Options granted
Weighted Average Exercise Price Expired
Weighted Average Exercise Price Forfeited options
Weighted Average Exercise Price Exercised
Weighted Average Exercise Price Outstanding, Ending
Weighted Average Fair Value Outstanding, Beginning
Weighted Average Fair Value Options granted
Weighted Average Fair Value Expired
Weighted Average Fair Value Forfeited options
Weighted Average Fair Value Exercised
Weighted Average Fair Value Outstanding, Ending
Weighted-average Remaining Contractual Life (years) Outstanding, Beginning
Weighted-average Remaining Contractual Life (years) Options granted
Weighted-average Remaining Contractual Life (years) Outstanding, Ending
Warrant Outstanding, Beginning
Warrant Outstanding, Warrants issued
Warrant Outstanding, Expired
Warrant Outstanding, Forfeited warrants
Warrant Outstanding, Exercised
Warrant Outstanding, Ending
Weighted Average Exercise Price, Beginning
Weighted Average Exercise Price, Warrant issued
Weighted Average Exercise Price, Expired
Weighted Average Exercise Price, Forfeited warrants
Weighted Average Exercise Price, Exercised
Weighted Average Exercise Price, Ending
Weighted Average Fair Value, Beginning
Weighted Average Fair Value, Warrant issued
Weighted Average Fair Value, Expired
Weighted Average Fair Value, Forfeited warrants
Weighted Average Fair Value, Exercised
Weighted Average Fair Value, Ending
Weighted-average Remaining Contractual Life (Years), Beginning
Weighted-average Remaining Contractual Life (Years), Warrants issued
Weighted-average Remaining Contractual Life (Years), Exercised
Weighted-average Remaining Contractual Life (Years), Ending
Statistical Measurement [Axis]
Range of Exercise Prices
Range of Exercise Prices
Number outstanding
Weighted average remaining contractual life
Weighted average exercise price
Number exercisable
Weighted average exercise price exercisable
Total
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Accrued royalties
Royalty payments, per month
Due to related party
Area of land
Contract lease per month
Lease expiration date
Rent expenses
2019
2020
Total
CAD [Member]
Convertible Promissory Note [Member]
DNA Logix-Canada [Member]
Dr. Brent Satterfield [Member]
Dr. Satterfield [Member]
Exclusive License Agreement [Member]
0.11-0.55 [Member]
2.00-3.85 [Member]
0.11-7.20 [Member]
5.10-7.20 [Member]
Four Companies [Member]
Interest expense for accretion.
Joint Venture Agreement [Member]
Market Licensing Agreement [Member]
Nine Employees [Member]
Options [Member]
Outstanding Options [Member]
Outstanding Warrants [Member]
Up to $1,000,000 [Member]
$1,000,000-$2,000,000 [Member]
Above $3,000,000 [Member]
$2,000,000-$3,000,000 [Member]
Purchase price paid.
Robert Salna Promissory Note [Member]
Robert Salna Promissory Note Payable [Member]
Sales and Marketing [Member]
Series A Convertible Preferred Stock [Member]
The number of equity-based payment instruments, excluding stock (or unit) options, that were Exercised during the reporting period.
Share based compensation arrangement by share based payment award equity instruments other than options exercised weighted average grant date fair value.
The number of equity-based payment instruments, excluding stock (or unit) options, that were Expired during the reporting period.
Share based compensation arrangement by share based payment award equity instruments other than options expired weighted average grant date fair value.
Share based compensation arrangement by share based payment award equity instruments other than options weighted average exercised.
Share based compensation arrangement by share based payment award equity instruments other than options weighted average Expired.
Share based compensation arrangement by share based payment award equity instruments other than options weighted average forfeited.
Share based compensation arrangement by share based payment award equity instruments other than options weighted average grant,
Weighted-average Remaining Contractual Life (years) Options granted.
Share based compensation arrangement by share based payment award equity instruments other than options exercised weighted average grant date fair value.
Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible.
Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible.
Weighted average grant-date fair value of non-vested other than options outstanding.
Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
Six Individuals and Four Companies [Member]
Summary of Stock Option and Warrant Outstanding [Table Text Block]
Three Independent Members [Member]
Three Members Our Board of Directors [Member]
Two Companies [Member]
2018 [Member]
2015 Long-term Incentive Plan [Member]
2019 [Member]
2020 [Member]
Underwriting Agreement [Member]
WallachBeth Capital, LLC [Member]
Warrants [Member]
Payment of deferred offering costs.
Beneficial Ownership [Member]
Stock conversion price per share.
Stock issued during pPeriod value preferred stock.
Stock issued during period shares preferred stock.
Schedule of convertible preferred stock and stockholders equity [Table Text Block]
Issued and Outstanding Convertible Preferred Stock [Member]
Assets, Current
Assets, Noncurrent
Assets
Liabilities, Current
Liabilities, Noncurrent
Liabilities
Stockholders' Equity Attributable to Parent
Liabilities and Equity
Gross Profit
Operating Expenses
Operating Income (Loss)
Interest Expense, Other
Other Nonoperating Income (Expense)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Gain (Loss) on Extinguishment of Debt
Gain (Loss) on Sale of Equity Investments
Increase (Decrease) in Accounts and Other Receivables
Increase (Decrease) in Deferred Income Taxes
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Inventories
Net Cash Provided by (Used in) Operating Activities
Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Interest in Joint Venture
Net Cash Provided by (Used in) Investing Activities
Payments for Repurchase of Initial Public Offering
Net Cash Provided by (Used in) Financing Activities
Cash and Cash Equivalents, Period Increase (Decrease)
Shares, Outstanding
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
0.11-7.20 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit
Operating Leases, Future Minimum Payments Due